NYSE · Healthcare

RETRACTABLE TECHNOLOGIES INC (RVP)

As-reported financials and recent SEC filings for RETRACTABLE TECHNOLOGIES INC, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$38.3M

Net income

$-12.6M

Net margin

-32.8%

Diluted EPS

$-0.43

ROE

-16.9%

P/E (TTM)

—

Market cap

—

Debt / equity

0.0×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$38.3M	$33.0M	$43.6M	$94.8M	$188.4M
Gross profit	$47,046	$-1.0M	$9.1M	$28.3M	$95.4M
Operating income	$-21.2M	$-21.1M	$-11.5M	$-852,976	$72.6M
Net income	$-12.6M	$-11.9M	$-7.0M	$5.1M	$56.1M
Diluted EPS	$-0.43	$-0.40	$-0.24	$0.15	$1.63

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

8-K2026-06-30

8-K2026-05-15

10-Q2026-05-15

8-K2026-05-13

8-K2026-04-10

8-K2026-03-27

10-K2026-03-27

DEFA14A2026-03-27

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on RVP

Search RETRACTABLE TECHNOLOGIES INC’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.